spacer
home > ebr > spring 2006 > t-cell epitopes: predicting immunogenicity
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 
News and Press Releases

Illingworth Research launches PatientGO for patients on clinical trials

11 March 2020 - Macclesfield, United Kingdom. A NEW digital concierge service is being launched to help patients taking part in clinical trials. Illingworth Research Group (Illingworth), based in Macclesfield in the UK, has launched PatientGO, its in-house service oering concierge support to those who give their time to the development of new drugs.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement